In the mouse model, oral administration of ICAC significantly alleviated acute gastritis by preserving mucosal integrity, preventing prostaglandin E2 depletion, and enhancing Ptgs1 and Muc6 expression in mice, while suppressing inflammatory mediator production in gastric tissues. This evidence concerns the gene PTGS1 and gastritis.